Screening for coagulation disorders in patients with ischemic stroke

Area of Science:

• Neurology
• Hematology
• Genetics

Background:

• The link between coagulation disorders and ischemic stroke is not fully understood.
• Screening for these conditions and managing them post-stroke remains uncertain.

Purpose of the Study:

• To review data on coagulation abnormalities and ischemic stroke.
• To discuss the utility of screening and management strategies.

Main Methods:

• Literature review of inherited and acquired coagulation disorders.
• Analysis of their association with ischemic stroke.
• Evaluation of screening and management recommendations.

Main Results:

• Evidence on the role of specific coagulation abnormalities (e.g., Factor V Leiden, antiphospholipid syndrome) in ischemic stroke was reviewed.
• The clinical utility of screening and therapeutic implications were assessed.

Conclusions:

• The role of coagulation disorders in ischemic stroke pathogenesis requires further elucidation.
• Evidence-based recommendations for screening and management are discussed.